Acute gastrointestinal graft-versus-host disease in pediatric patients: Serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 7, 2011, Pages 1058-1066

  Goussetis, Evgenios ^a   Paisiou, Anna ^a   Kitra, Vasiliki ^a   Peristeri, Ioulia ^a   Vessalas, George ^a   Stefanaki, Kaliopi ^a   Panayotou, Ioanna ^b   Giamaiou, Konstantina ^a   Kontou, Eleftheria ^a   Kitzoni, Margaret ^a   Dimopoulou, Maria N ^a   Karkelis, Savvas ^b   Kafritsa, Yota ^b   Rapsomaniki, Eleni ^c   Papassotiriou, Ioannis ^a   Tsirigotis, Panagiotis ^d   Roma, Eleftheria ^b   Graphakos, Stelios ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

AGVHD; Early predictor; Gastrointestinal; Serum albumin

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; INFLIXIMAB; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTIDE; SERUM ALBUMIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FANCONI ANEMIA; FEMALE; GASTROINTESTINAL ACUTE GRAFT VERSUS HOST DISEASE; GRAFT VERSUS HOST REACTION; HEMOGLOBINOPATHY; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOID LEUKEMIA; NONRELAPSE MORTALITY; ORGAN DONOR; OVERALL SURVIVAL; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ALBUMINURIA; ANEMIA, APLASTIC; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; METHYLPREDNISOLONE; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958716790     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.11.005     Document Type: Article

References (38)

1. Eapen M., Horowitz M.M., Klein J.P., et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004, 22:4872-4880.
2. Giebel S., Giorgiani G., Martinetti M., et al. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high resolution molecular typing. Bone Marrow Transplant 2003, 31:987-993.
3. Rocha V., Cornish J., Sievers E.L., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97:2962-2971.
4. Eisner M.D., August C.S. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant 1995, 15:663-668.
5. Martin P., Bleyzac N., Souillet G., et al. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors. Bone Marrow Transplant 2003, 32:881-887.
6. Vogelsang G.B., Lee L., Bensen-Kennedy D.M. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003, 54:29-52.
7. Martin P.J., McDonald G.B., Sanders J.E., et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004, 10:320-327.
8. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
9. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997, 97:855-864.
10. Iqbal N., Salzman D., Lazenby A.J., Wilcox C.M. Diagnosis of gastrointestinal graft-versus-host disease. Am J Gastroenterol 2000, 95:3034-3038.
11. Cox G.J., Matsui S.M., Lo R.S., et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994, 107:1398-1407.
12. Wu D., Hockenberry D.M., Brentnall T.A., et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation 1998, 66:1319-1324.
13. Jacobsohn D.A. Acute graft-versus-host disease in children. Bone Marrow Transplant 2008, 41:215-221.
14. Martin P., Nash R., Sanders J., et al. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1998, 21:273-279.
15. Deeg H.J. How I treat refractory acute GVHD. Blood 2007, 109:4119-4126.
16. Choi S.W., Kitko C.L., Braun T., et al. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood 2008, 112:1539-1542.
17. Fuji S., Kim S.W., Fukuda T., et al. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008, 14:510-517.
18. Paczesny S., Krijanovski O.I., Braun T.M., et al. A biomarker panel for acute graft-versus-host disease. Blood 2009, 113:273-278.
19. Melson J., Jakate S., Fung H., Arai S., Keshavarzian A. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol 2007, 82:881-886.
20. Bombi J., Nadal A., Carreras E., et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol 1995, 103:690-695.
21. R Development Core Team (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL R-version 2.12.1 released on 2010-12-16. http://www.R-project.org.
22. Kharfan-Dabaja M., Chavez J., Yu D., et al. Severe hypoalbuminemia at day 90 predicts worse non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2010 July 21, [Epub ahead of print].
23. Lee K.-H., Choi S.-J., Lee J.-H., et al. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Haematologica 2005, 90:939-948.
24. De Roock W., Claes B., Bernasconi D., et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 2010, 11:753-762.
25. Nydegger A., Catto-Smith A.G., Tiedemann K., Hardikar W. Diagnosis of gastrointestinal graft-versus-host disease-Is rectal biopsy enough?. Pediatr Blood Cancer 2007, 48:561-566.
26. Barker C.C., Anderson R.A., Sauve R.S., Butzner J.D. GI complications in pediatric patients post-BMT. Bone Marrow Transplant 2005, 36:51-58.
27. Michel D., Marre E., Hampl W., et al. Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples. J Clin Microbiol 1995, 33:3064-3067.
28. Herfarth H.H., Long M.D., Rubinas T.C., et al. Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study. Dig Dis Sci 2010, 55:1053-1058.
29. Weisdorf D., Haake R., Blazar B., et al. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 1990, 75:1024-1030.
30. MacMillan M.L., Weisdorf D.F., Wagner J.E., et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant 2002, 8:387-394.
31. Van Lint M.T., Milone G., Leotta S., et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood 2006, 107:4177-4181.
32. Stelljes M., Hermann S., Albring J., et al. Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood 2008, 111:2909-2918.
33. Socié G., Mary J.Y., Lemann M., et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood 2004, 103:50-57.
34. Fallows G., Rubinger M., Bernstein C.N. Does gastroenterology consultation change management of patients receiving hematopoietic stem cell transplantation?. Bone Marrow Transplant 2001, 28:289-294.
35. MacMillan M., DeFor T.E., Weisdorf D.J. The best endpoint for acute GVHD treatment trials. Blood 2010, 115:5412-5417.
36. Levine J.E., Logan M.S.B., Wu J., et al. Graft-versus-host disease treatment: Predictors of survival. Biol Blood Marrow Transplant 2010 May 27, [Epub ahead of print].
37. Don B.R., Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004, 17:432-437.
38. Weisdorf S.A., Salati L.M., Longsdorf J.A., Ramsay N.K., Sharp H.L. Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antithrypsin. Gastroenterology 1983, 85:1076-1081.